Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11918659rdf:typepubmed:Citationlld:pubmed
pubmed-article:11918659lifeskim:mentionsumls-concept:C0596972lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0085196lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0011164lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0205329lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0021044lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C1521743lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0181904lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C1704646lld:lifeskim
pubmed-article:11918659lifeskim:mentionsumls-concept:C0728873lld:lifeskim
pubmed-article:11918659pubmed:issue6lld:pubmed
pubmed-article:11918659pubmed:dateCreated2002-3-28lld:pubmed
pubmed-article:11918659pubmed:abstractTextWe investigated the microglial response to progressive dopamine neuron degeneration using in vivo positron emission tomography (PET) imaging and postmortem analyses in a Parkinson's disease (PD) rat model induced by unilateral (right side) intrastriatal administration of 6-hydroxydopamine (6-OHDA). Degeneration of the dopamine system was monitored by PET imaging of presynaptic dopamine transporters using a specific ligand (11)C-CFT (2beta-carbomethoxy-3beta-(4-fluorophenyl) tropane). Binding of (11)C-CFT was markedly reduced in the striatum indicating dopaminergic degeneration. Parallel PET studies of (11)C-PK11195 (1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3 isoquinoline carboxamide) (specific ligand for activated microglia) showed increased binding in the striatum and substantia nigra indicative of a microglial response. Postmortem immunohistochemical analyses were performed with antibodies against CR3 for microglia/macrophage activation. Using a qualitative postmortem index for microglial activation we found an initially focal, then widespread microglial response at striatal and nigral levels at 4 weeks postlesion. These data support the hypothesis that inflammation is a significant component of progressive dopaminergic degeneration that can be monitored by PET imaging.lld:pubmed
pubmed-article:11918659pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:languageenglld:pubmed
pubmed-article:11918659pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:citationSubsetIMlld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11918659pubmed:statusMEDLINElld:pubmed
pubmed-article:11918659pubmed:monthMarlld:pubmed
pubmed-article:11918659pubmed:issn0953-816Xlld:pubmed
pubmed-article:11918659pubmed:authorpubmed-author:WilliamsKKlld:pubmed
pubmed-article:11918659pubmed:authorpubmed-author:LivneAAlld:pubmed
pubmed-article:11918659pubmed:authorpubmed-author:ChenY IYIlld:pubmed
pubmed-article:11918659pubmed:authorpubmed-author:CicchettiFFlld:pubmed
pubmed-article:11918659pubmed:authorpubmed-author:IsacsonOOlld:pubmed
pubmed-article:11918659pubmed:authorpubmed-author:BrownellA LALlld:pubmed
pubmed-article:11918659pubmed:issnTypePrintlld:pubmed
pubmed-article:11918659pubmed:volume15lld:pubmed
pubmed-article:11918659pubmed:ownerNLMlld:pubmed
pubmed-article:11918659pubmed:authorsCompleteYlld:pubmed
pubmed-article:11918659pubmed:pagination991-8lld:pubmed
pubmed-article:11918659pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:meshHeadingpubmed-meshheading:11918659...lld:pubmed
pubmed-article:11918659pubmed:year2002lld:pubmed
pubmed-article:11918659pubmed:articleTitleNeuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.lld:pubmed
pubmed-article:11918659pubmed:affiliationNeuroregeneration Laboratory, MRC119, McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA.lld:pubmed
pubmed-article:11918659pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11918659pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11918659pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11918659lld:pubmed
More...